Health ❯ Healthcare ❯ Diagnostics

Biomarkers

Blood Tests pTau217 Blood-based Biomarkers Circulating Tumor DNA C2N Diagnostics Urine Tests Urine Biomarkers eMTBR-tau243 Sweat Analysis Blood-Based Biomarkers

34‑circRNA Blood Signature Outperforms pTau217 in Detecting and Predicting Alzheimer’s

The validated blood panel could allow earlier, noninvasive risk screening pending larger prospective studies and regulatory review.

Blood Tests and New PET Tracer Reveal Early Alzheimer’s Signals in Some Middle‑Aged Adults

Cambridge Nanosensor Shows Urine Signal for Early Lung Cancer

Home Blood Test and Online Checks Flag Alzheimer’s Risk in Small Study

Blood Test Detects Alzheimer’s Risk Years Before PET Scans

CSF Enzyme Marker Distinguishes Parkinson’s and Lewy Body Dementia From Alzheimer’s

p‑Tau217 Blood Tests Boost Alzheimer’s Diagnosis and Predict Onset Within a Few Years

NIH-Supported Study Unveils Four-Marker Blood Test for Earlier Detection of Pancreatic Cancer

Finger‑Prick Alzheimer’s Blood Test Moves Forward in International Trial With 883 Enrolled

Finger-Prick Blood Spot Test Detects Alzheimer’s Biomarkers With 86% Accuracy

Finger-Prick Dried Blood Test Flags Alzheimer’s Biomarkers in European Study

UTS Review Sets Roadmap for Sweat‑Sensing Wearables in Real‑Time Health Monitoring

FDA Clears Roche and Lilly’s Elecsys Blood Test to Help Rule Out Alzheimer’s in Symptomatic Adults 55+

Early ctDNA Test Flags Which LS-SCLC Patients Benefit From Consolidation Immunotherapy

Urine Test From Johns Hopkins Uses Three Biomarkers to Spot Prostate Cancer With High Accuracy

Kennedy Krieger Review Maps Biomarkers to Earlier Sturge-Weber Care, Paving Way for Trials

AI Acoustic Analysis Reveals Early Laryngeal Cancer Markers in Men’s Voices

First-Trimester Gut Microbiome Signatures Predict Gestational Diabetes

New Blood Test Pinpoints Liver Transplant Rejection and Cellular Origins of Damage

Blood-Based Immune Gene Signature Offers Early Parkinson’s Detection